Isozaki, H., Takigawa, N., & Kiura, K. (2015). Mechanisms of Acquired Resistance to ALK Inhibitors and the Rationale for Treating ALK-positive Lung Cancer. Cancers (Basel).
Citação norma ChicagoIsozaki, Hideko, Nagio Takigawa, and Katsuyuki Kiura. "Mechanisms of Acquired Resistance to ALK Inhibitors and the Rationale for Treating ALK-positive Lung Cancer." Cancers (Basel) 2015.
Citação norma MLAIsozaki, Hideko, Nagio Takigawa, and Katsuyuki Kiura. "Mechanisms of Acquired Resistance to ALK Inhibitors and the Rationale for Treating ALK-positive Lung Cancer." Cancers (Basel) 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.